Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 206, Issue 10, Pages 2131-2139Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20090639
Keywords
-
Categories
Funding
- National Institutes of Health [NIH-AI53102]
- Leopoldina research fellowship [BMBF-LPD 9901/8-184]
- LOEWE (LiFF) program of the federal state of Hessen, Germany
Ask authors/readers for more resources
It has been reported that retinoic acid (RA) enhances regulatory T (T reg) cell conversion by inhibiting the secretion of cytokines that interfere with conversion. This report shows that these conclusions provide a partial explanation at best. First, RA not only interfered with cytokine secretion but also with the ability of these cytokines to inhibit T reg cell conversion of naive T cells. Furthermore, RA enhanced conversion even in the absence of inhibitory cytokines. The latter effect depended on the RA receptor alpha (RAR alpha) but did not require Smad3, despite the fact that RA enhanced Smad3 expression. The RAR alpha 1 isoform was not essential for RA-dependent enhancement of transforming growth factor beta-driven conversion, suggesting that conversion can also be mediated by RAR alpha 2. Interleukin (IL)-6 strongly reduced RAR alpha expression levels such that a deficiency of the predominant RAR alpha 1 isoform leaves too little RAR alpha 2 for RA to inhibit the generation of Th17 cells in the presence of IL-6.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available